Back to search
FDAFDA · Food and drugs·Recall number D-0758-2026

Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-101-30.

Published July 29, 2026 · Recall initiated: July 6, 2026

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications

What to do

Voluntary: Firm initiated · Letter

Recall details

Brand
TROKENDI XR
Manufacturer
Supernus Pharmaceuticals, Inc.
Distributor
US Nationwide.
UPC
0317772101300
Lot
Lot # 2075801, Exp Date: 31-Oct-2029.
Risk classification
Class III
Area (FDA)
drug
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card